{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:10:23Z","timestamp":1776406223974,"version":"3.51.2"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:00:00Z","timestamp":1593734400000},"content-version":"am","delay-in-days":368,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jaip.2019.01.057","type":"journal-article","created":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T12:01:35Z","timestamp":1550232095000},"page":"1894-1900","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Low Cross-Reactivity Between Cisplatin and Other Platinum Salts"],"prefix":"10.1016","volume":"7","author":[{"given":"Justine","family":"Pasteur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laure","family":"Favier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinne","family":"Pernot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathieu","family":"Guerriaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Bernigaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00f4me","family":"Lepage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Louis","family":"Jouve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Isambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyne","family":"Collet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2019.01.057_bib1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaip.2013.08.011","article-title":"Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization","volume":"2","author":"Wong","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2019.01.057_bib2","doi-asserted-by":"crossref","first-page":"168","DOI":"10.18176\/jiaci.0038","article-title":"A\u00a0new practical desensitization protocol for oxaliplatin-induced immediate hypersensitivity reactions: a necessary and useful approach","volume":"26","author":"Park","year":"2016","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2019.01.057_bib3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/030089169908500418","article-title":"Hypersensitivity reaction to carboplatin during treatment for ovarian cancer: successful resolution by replacement with cisplatin","volume":"85","author":"Shukunami","year":"1999","journal-title":"Tumori"},{"key":"10.1016\/j.jaip.2019.01.057_bib4","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10147-009-0883-6","article-title":"Oxaliplatin-induced allergic reaction in patients with colorectal cancer in Japan","volume":"14","author":"Shibata","year":"2009","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.jaip.2019.01.057_bib5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ctrv.2008.11.002","article-title":"Head and neck cancer in the elderly: an overview on the treatment modalities","volume":"35","author":"Syrigos","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jaip.2019.01.057_bib6","first-page":"227","article-title":"Cellular and molecular pharmacology of oxaliplatin","volume":"1","author":"Raymond","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jaip.2019.01.057_bib7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy","volume":"7","author":"Kelland","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jaip.2019.01.057_bib8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000055363","article-title":"Hypersensitivity reactions to carboplatin administration are common but not always severe: a 10-year experience","volume":"61","author":"Polyzos","year":"2001","journal-title":"Oncology"},{"key":"10.1016\/j.jaip.2019.01.057_bib9","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ygyno.2006.04.002","article-title":"Evaluation of the incidence of carboplatin hypersensitivity reactions in cancer patients","volume":"103","author":"Navo","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jaip.2019.01.057_bib10","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.ejca.2005.06.021","article-title":"Allergic-type reactions to oxaliplatin: retrospective analysis of 42 patients","volume":"41","author":"Maindrault-Goebel","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jaip.2019.01.057_bib11","first-page":"89","article-title":"Severe anaphylactic reactions in patients receiving oxaliplatin therapy: a rare but potentially fatal complication","volume":"15","author":"Lee","year":"2007","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jaip.2019.01.057_bib12","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.3748\/wjg.v18.i38.5427","article-title":"Oxaliplatin-induced severe anaphylactic reactions in metastatic colorectal cancer: case series analysis","volume":"18","author":"Wang","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jaip.2019.01.057_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/ijgc-00009577-200501000-00003","article-title":"Carboplatin hypersensitivity","volume":"15","author":"Sliesoraitis","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jaip.2019.01.057_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/207084","article-title":"Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review","volume":"2010","author":"Makrilia","year":"2010","journal-title":"Met-Based Drugs"},{"key":"10.1016\/j.jaip.2019.01.057_bib15","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1200\/JCO.1999.17.4.1141","article-title":"Clinical features of hypersensitivity reactions to carboplatin","volume":"17","author":"Markman","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaip.2019.01.057_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2050-6511-15-1","article-title":"Hypersensitivity to oxaliplatin: clinical features and risk factors","volume":"15","author":"Parel","year":"2014","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.jaip.2019.01.057_bib17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ygyno.2006.10.047","article-title":"Does the platinum-free interval predict the incidence or severity of hypersensitivity reactions to carboplatin? The experience from Women and Infants\u2019 Hospital","volume":"105","author":"Schwartz","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jaip.2019.01.057_bib18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00280-010-1338-5","article-title":"Risk factors contributing to the development of carboplatin-related delayed hypersensitivity reactions in Japanese patients with gynecologic cancers","volume":"67","author":"Sugimoto","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jaip.2019.01.057_bib19","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ygyno.2011.04.019","article-title":"Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: analysis from the GCIG CALYPSO relapsing ovarian cancer trial","volume":"122","author":"Joly","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jaip.2019.01.057_bib20","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1164\/ajrccm.160.2.9807065","article-title":"Interaction of HLA phenotype and exposure intensity in sensitization to complex platinum salts","volume":"160","author":"Newman Taylor","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2019.01.057_bib21","doi-asserted-by":"crossref","first-page":"641","DOI":"10.7150\/ijms.7643","article-title":"Serum lactate dehydrogenase levels as a predictive marker of oxaliplatin-induced hypersensitivity reactions in Japanese patients with advanced colorectal cancer","volume":"11","author":"Seki","year":"2014","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.jaip.2019.01.057_bib22","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jaci.2006.11.640","article-title":"Diagnostic and predictive value of skin testing in platinum salt hypersensitivity","volume":"119","author":"Leguy-Seguin","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.01.057_bib23","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1200\/JCO.2003.05.539","article-title":"Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity","volume":"21","author":"Markman","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaip.2019.01.057_bib24","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1200\/JCO.2001.19.12.3126","article-title":"Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy","volume":"19","author":"Zanotti","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jaip.2019.01.057_bib25","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jaip.2015.07.003","article-title":"Skin testing in the evaluation and management of carboplatin-related hypersensitivity reactions","volume":"3","author":"Lax","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2019.01.057_bib26","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1006\/gyno.2001.6519","article-title":"Analysis of patients with epithelial ovarian cancer or fallopian tube carcinoma retreated with cisplatin after the development of a carboplatin allergy","volume":"84","author":"Dizon","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jaip.2019.01.057_bib27","doi-asserted-by":"crossref","first-page":"199.e1","DOI":"10.1016\/j.ajog.2007.04.044","article-title":"Use of cisplatin without desensitization after carboplatin hypersensitivity reaction in epithelial ovarian and primary peritoneal cancer","volume":"197","author":"Callahan","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaip.2019.01.057_bib28","first-page":"197","article-title":"Rechallenge with cisplatin in a patient with pancreatic cancer who developed a hypersensitivity reaction to oxaliplatin. Is skin test useful in this setting?","volume":"9","author":"Elligers","year":"2008","journal-title":"JOP"},{"key":"10.1016\/j.jaip.2019.01.057_bib29","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jaci.2008.02.044","article-title":"Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases","volume":"122","author":"Castells","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.01.057_bib30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1034\/j.1600-0536.2001.450601.x","article-title":"Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions","volume":"45","author":"Barbaud","year":"2001","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2019.01.057_bib31","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jaci.2004.04.029","article-title":"Clinical features and severity grading of anaphylaxis","volume":"114","author":"Brown","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.01.057_bib32","first-page":"92","article-title":"Asthma caused by the complex salts of platinum","volume":"2","author":"Hunter","year":"1945","journal-title":"Br J Ind Med"},{"key":"10.1016\/j.jaip.2019.01.057_bib33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00280-009-1159-6","article-title":"Cisplatin administration following carboplatin desensitization failure in primary peritoneal cancer: a brief report","volume":"66","author":"Greene","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jaip.2019.01.057_bib34","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ygyno.2014.07.104","article-title":"Outpatient rapid 4-step desensitization for gynecologic oncology patients with mild to low-risk, moderate hypersensitivity reactions to carboplatin\/cisplatin","volume":"135","author":"Li","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jaip.2019.01.057_bib35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11882-015-0515-3","article-title":"Presentation and diagnosis of hypersensitivity to platinum drugs","volume":"15","author":"Caiado","year":"2015","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2019.01.057_bib36","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1081-1206(10)60410-3","article-title":"Usefulness of skin testing with platinum salts to demonstrate lack of cross-reactivity between carboplatin and cisplatin","volume":"100","author":"Enrique","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2019.01.057_bib37","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.annder.2017.05.016","article-title":"[Hypersensitivity to platinum salts and taxanes: the value of skin tests and tolerance induction procedures]","volume":"144","author":"Brault","year":"2017","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaip.2019.01.057_bib38","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jaip.2013.06.002","article-title":"Carboplatin-, oxaliplatin-, and cisplatin-specific IgE: cross-reactivity and value in the diagnosis of carboplatin and oxaliplatin allergy","volume":"1","author":"Caiado","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2019.01.057_bib39","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/IGC.0000000000000307","article-title":"Oxaliplatin is a safe alternative option for patients with recurrent gynecologic cancers after hypersensitivity reaction to Carboplatin","volume":"25","author":"Kolomeyevskaya","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jaip.2019.01.057_bib40","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/CAD.0b013e32833418c0","article-title":"Administration of cisplatin in three patients with carboplatin hypersensitivity: is skin testing useful?","volume":"21","author":"Syrigou","year":"2010","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.jaip.2019.01.057_bib41","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/ijgc-00009577-200509000-00011","article-title":"Cisplatinum rechallenge in relapsed ovarian cancer patients with platinum reinduction therapy and carboplatin hypersensitivity","volume":"15","author":"Kandel","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jaip.2019.01.057_bib42","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/030089160308900315","article-title":"Cisplatin may be a valid alternative approach in ovarian carcinoma with carboplatin hypersensitivity. Report of three cases","volume":"89","author":"Libra","year":"2003","journal-title":"Tumori"},{"key":"10.1016\/j.jaip.2019.01.057_bib43","first-page":"335","article-title":"Hypersensitivity reaction to carboplatin: successful resolution by replacement with cisplatin","volume":"23","author":"Porzio","year":"2002","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.jaip.2019.01.057_bib44","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1002\/1097-0142(19940415)73:8<2218::AID-CNCR2820730830>3.0.CO;2-1","article-title":"Hypersensitivity reactions to carboplatin. Report of two patients, review of the literature, and discussion of diagnostic procedures and management","volume":"73","author":"Weidmann","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.jaip.2019.01.057_bib45","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ygyno.2016.10.023","article-title":"Cisplatin can be safely administered to ovarian cancer patients with hypersensitivity to carboplatin","volume":"144","author":"Bergamini","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jaip.2019.01.057_bib46","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/gyno.1994.1098","article-title":"Death from anaphylaxis to cisplatin: a case report","volume":"53","author":"Zweizig","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jaip.2019.01.057_bib47","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF00689458","article-title":"Hypersensitivity and cross-reactivity to cisplatin and analogues","volume":"35","author":"Shlebak","year":"1995","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jaip.2019.01.057_bib48","first-page":"3465","article-title":"Safety of cisplatin after severe hypersensitivity reactions to carboplatin in patients with recurrent ovarian carcinoma","volume":"23","author":"Ottaiano","year":"2003","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jaip.2019.01.057_bib49","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jaip.2017.03.015","article-title":"Immediate hypersensitivity reaction to chemotherapeutic agents","volume":"5","author":"Giavina-Bianchi","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219819301679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219819301679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:18:01Z","timestamp":1761974281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219819301679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S2213219819301679"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2019.01.057","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low Cross-Reactivity Between Cisplatin and Other Platinum Salts","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2019.01.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}